Publications & Posters CIMT 2023: Application of the microbiome-based prediction test BiomeOne quantifies antibiotic, geographical and health-related effects on response to cancer immunotherapy in a large European cohortCatia PacificoMay 5, 2023
Publications & Posters Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening programCatia PacificoFebruary 17, 2023
Publications & Posters Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitisCatia PacificoNovember 22, 2022
Publications & Posters DGHO 2022: BiomeOne®: multi-centric validation of a novel microbiome-based test to predict response to cancer immunotherapyCatia PacificoOctober 11, 2022
Publications & Posters UEG 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening toolCatia PacificoOctober 11, 2022
Publications & Posters Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)Catia PacificoOctober 1, 2022
Publications & Posters ÖGP 2022: Prediction of immune checkpoint inhibitor response in non-small cell lung cancer patients using a microbiome-based biomarkerCatia PacificoOctober 1, 2022
Publications & Posters ÖGMBT 2022: Deconfounding the intestinal microbiome signature of responders versus non- responders to immune checkpoint inhibitor therapiesCatia PacificoSeptember 26, 2022
Publications & Posters ESMO 2022: BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapyCatia PacificoSeptember 19, 2022
Publications & Posters ÖGGH 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening toolNikolaus GascheSeptember 9, 2022
